Loading organizations...
§ Venture Capital · Shenzhen, Guangdong, China
International private equity firm specializing in venture capital and private equity investments for medical and health industry companies.
DiNovA Capital is an international private equity investment institution dedicated to the medical and health industry. The firm invests in entrepreneurial and growth-stage companies, integrating world-class medical technologies into China. This strategy prioritizes product enhancement, cost reduction, and rapid global delivery of advanced healthcare solutions.
The firm's foundation is its management team, with deep experience in healthcare entrepreneurship, investment, and management. This expertise underpins its international investment scope, spanning the United States, Israel, Europe, and China. DiNovA Capital collaborates with global industry experts and major healthcare institutions to identify promising ventures.
DiNovA Capital targets innovative healthcare companies, facilitating technology transfer and market expansion to create substantial value. Its vision delivers strong investor returns by ensuring pioneering medical innovations quickly reach global markets, benefiting a wider population with advanced solutions.
DiNovA Capital has 1 tracked investment across 1 company. The latest tracked deal is $23.0M Series B in Vessix Vascular in August 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 1, 2011 | Vessix Vascular | $23.0M Series B | — | Andera Partners, Christopher Weil & Company, Fjord Invest, Neomed Management, Vince Burgess |